Phase II trial of carboplatin/paclitaxel and cetuximab, followed by carboplatin/paclitaxel/cetuximab and erlotinib, in metastatic or recurrent squamous cell carcinoma of the head and neck. Bhatia, A. K., Mehra, R., Khan, S. A., Egleston, B. L., Alpaugh, R., Lango, M., Ridge, J. A., Burtness, B. AMER SOC CLINICAL ONCOLOGY. 2016

View details for DOI 10.1200/JCO.2016.34.15_suppl.6027

View details for Web of Science ID 000404711502154